Literature DB >> 9849618

CD100 is a leukocyte semaphorin.

S Delaire1, A Elhabazi, A Bensussan, L Boumsell.   

Abstract

CD100 was originally described as an activation molecule on the surface of human T lymphocytes. Its triggering through distinct epitopes leads to different signals of costimulation with phorbol myristate acetate (PMA) or with CD3 and CD2. Interestingly, CD100 was shown to associate with different partner molecules in T cells. First, CD100 can associate with CD45, a key molecule with protein tyrosine phosphatase activity involved in T-cell transduction: this association is physical and has functional consequences for both partners. Second, CD100 interacts in its cytoplasmic domain with a Ser/Thr kinase for which it represents a preferential substrate. Recently, CD100 was identified as a member of the semaphorin gene family. This family comprises approximately 20 structurally related proteins. The first semaphorins were identified in the developing nervous system. Function has been shown for only some of them and involves repulsion during growth cone guidance. Since CD100 was the first semaphorin identified in the immune system, this raises the possibility of the involvement of members of the semaphorin family in other physiological phenomena outside the nervous system.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9849618     DOI: 10.1007/s000180050252

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  29 in total

Review 1.  Positive and negative roles of CD72 in B cell function.

Authors:  Hsin-Jung Wu; Subbarao Bondada
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Regulation of immune cell responses by semaphorins and their receptors.

Authors:  Hyota Takamatsu; Tatsusada Okuno; Atsushi Kumanogoh
Journal:  Cell Mol Immunol       Date:  2010-02-01       Impact factor: 11.530

3.  Semaphorin SEMA3F localization in malignant human lung and cell lines: A suggested role in cell adhesion and cell migration.

Authors:  E Brambilla; B Constantin; H Drabkin; J Roche
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 4.  Semaphorins: a new class of immunoregulatory molecules.

Authors:  Noriko Takegahara; Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

5.  Antitumor Effects of Anti-Semaphorin 4D Antibody Unravel a Novel Proinvasive Mechanism of Vascular-Targeting Agents.

Authors:  Iratxe Zuazo-Gaztelu; Marta Pàez-Ribes; Patricia Carrasco; Laura Martín; Adriana Soler; Mar Martínez-Lozano; Roser Pons; Judith Llena; Luis Palomero; Mariona Graupera; Oriol Casanovas
Journal:  Cancer Res       Date:  2019-06-25       Impact factor: 12.701

Review 6.  Neuroimmune semaphorins as costimulatory molecules and beyond.

Authors:  Svetlana P Chapoval
Journal:  Mol Med       Date:  2018-04-04       Impact factor: 6.354

Review 7.  Biology and function of neuroimmune semaphorins 4A and 4D.

Authors:  EusebiusHenry Nkyimbeng-Takwi; Svetlana P Chapoval
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

Review 8.  T-cells in neuronal injury and repair: semaphorins and related T-cell signals.

Authors:  Pascale Giraudon; Peggy Vincent; Carine Vuaillat
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

9.  A novel role for the semaphorin Sema4D in the induction of allo-responses.

Authors:  Raimon Duran-Struuck; Isao Tawara; Kathi Lowler; Shawn G Clouthier; Elizabeth Weisiger; Clare Rogers; Gary Luker; Atsushi Kumanogoh; Chen Liu; James L M Ferrara; Pavan Reddy
Journal:  Biol Blood Marrow Transplant       Date:  2007-09-21       Impact factor: 5.742

10.  Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells.

Authors:  Rania H Younis; Kyu Lee Han; Tonya J Webb
Journal:  J Immunol       Date:  2016-01-06       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.